# Kyntra Bio, Inc.: Form 8-K, filed Apr 9, 2026

- Company: [Kyntra Bio, Inc.](/companies/kynb.md) (CIK 921299)
- Form: 8-K
- Filed: 2026-04-09
- Accepted by EDGAR: Apr 9, 2026, 20:10 ET
- Period: 2026-04-02
- Accession: 0001193125-26-149624
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/921299/000119312526149624/kynb-20260402.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/921299/000119312526149624/

## Items reported

- Item 3.01: Delisting notice

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/921299/000119312526149624/kynb-20260402.htm

Filed Apr 9, 2026.
Source: SEC EDGAR, the filing index for accession 0001193125-26-149624. Last ingested by Listed: Oct 24, 2026, 15:00 ET. No prices; not investment advice.
